BioAtla (BCAB) Total Current Liabilities (2020 - 2026)

BioAtla's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $20.7 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 29.28% year-over-year to $20.7 million in Q1 2026; TTM through Mar 2026 was $20.7 million, a 29.28% increase from a year earlier, with the FY2025 full-year figure at $21.9 million, up 50.77% from the prior year.
• Total Current Liabilities eased to $20.7 million in Q1 2026 per BCAB's latest filing, from $21.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $35.6 million in Q3 2023 and bottomed at $14.5 million in Q4 2024.
• The 5-year median for Total Current Liabilities is $20.7 million (2026), against an average of $22.2 million.
• Across the five-year window, Total Current Liabilities surged 52.78% in 2023 and plunged 48.7% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $23.1 million in 2022, then rose by 22.54% to $28.3 million in 2023, then plunged by 48.7% to $14.5 million in 2024, then jumped by 50.77% to $21.9 million in 2025, then dropped by 5.61% to $20.7 million in 2026.
• Per Business Quant, the three latest BCAB Total Current Liabilities figures stand at $20.7 million (Q1 2026), $21.9 million (Q4 2025), and $18.0 million (Q3 2025).